To test this hypothesis, we analysed p21, p53 and P-S6 protein levels by immunohistochemistry (IHC) in a large series (n=274) of paraffin-embedded tumour samples from surgically treated HNSCC patients. The gene discussed is OCA2; the disease is head and neck squamous cell carcinoma.